CAM
MRNA icon

Costello Asset Management’s Moderna MRNA Stock Holding History

Costello Asset Management’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$63K Hold
900
– – 0.02% 218
2026
Q1 		$45.7K Hold
900
– – 0.02% 245
2025
Q4 		$26.5K Hold
900
– – 0.01% 335
2025
Q3 		$23.2K Sell
900
-156
-15% -$4.35K 0.01% 355
2025
Q2 		$29.1K Hold
1,056
– – 0.01% 316
2025
Q1 		$29.9K Buy
+1,056
New +$37.5K 0.01% 296
2023
Q4 		– Sell
-40
Closed -$4.13K – 191
2023
Q3 		$4.13K Hold
40
– – ﹤0.01% 169
2023
Q2 		$4.86K Hold
40
– – ﹤0.01% 161
2023
Q1 		$6.14K Sell
40
-40
-50% -$6.6K 0.01% 167
2022
Q4 		$14.4K Sell
80
-77
-49% -$12.6K 0.01% 138
2022
Q3 		$19K Buy
157
+17
+12% +$2.58K 0.02% 125
2022
Q2 		$20K Sell
140
-100
-42% -$14.3K 0.02% 131
2022
Q1 		$41K Buy
240
+175
+269% +$29.5K 0.03% 118
2021
Q4 		$17K Sell
65
-120
-65% -$35.1K 0.01% 157
2021
Q3 		$71K Buy
185
+60
+48% +$22.1K 0.05% 94
2021
Q2 		$29K Buy
125
+75
+150% +$13.4K 0.02% 132
2021
Q1 		$7K Hold
50
– – ﹤0.01% 201
2020
Q4 		$5K Sell
50
-50
-50% -$5.06K ﹤0.01% 208
2020
Q3 		$7K Buy
+100
New +$6.97K 0.01% 179

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

Costello Asset Management's MRNA Position: Q2 2026 in Review

Costello Asset Management held its Moderna (MRNA) position steady in Q2 2026 at 900 shares worth $63K. The position accounts for 0.02% of the portfolio, ranked #218.

Costello Asset Management first reported a position in MRNA in Q3 2020 and has held it in 19 quarters since. The position peaked at $71K in Q3 2021. 782 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • Costello Asset Management held 900 shares of Moderna worth $63K as of Q2 2026.
  • Costello Asset Management left its Moderna share count unchanged in Q2 2026.
  • Moderna made up 0.02% of Costello Asset Management's portfolio in Q2 2026, its #218 holding.
  • Costello Asset Management first reported a position in Moderna in Q3 2020 and has held it in 19 quarters since.
  • Costello Asset Management's Moderna position peaked at $71K in Q3 2021.
  • 782 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Costello Asset Management's 13F filing for Q2 2026, filed 28 Jul 2026.